首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis
【24h】

The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis

机译:不同腹膜透析液对氨苄西林,达托霉素和利奈唑胺体外抗粪肠球菌活性的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Intraperitoneal administration of antibiotics is recommended for the treatment of peritoneal dialysis-related peritonitis. However, little data are available on a possible interference between peritoneal dialysis fluids and the activity of antimicrobial agents. Thus, the present in vitro study set out to investigate the influence of different peritoneal dialysis fluids on the antimicrobial activity of ampicillin, linezolid, and daptomycin against Enterococcus faecalis. Time-kill curves in four different peritoneal dialysis fluids were performed over 24 h with four different concentrations (1 x MIC, 4 x MIC, 8 x MIC, 30 x MIC) of each antibiotic evaluated. Cation-adjusted Mueller-Hinton broth was used as the comparator solution. All four peritoneal dialysis fluids evaluated had a bacteriostatic effect on the growth of Enterococcus faecalis. Compared to the cation-adjusted Mueller-Hinton broth comparator solution, the antimicrobial activity of all antibiotics tested was reduced. For ampicillin and linezolid, no activity was found in any peritoneal dialysis fluid, regardless of the concentration. Daptomycin demonstrated dose-dependent activity in all peritoneal dialysis fluids. Bactericidal activity was observed at the highest concentrations evaluated in Dianeal (R) PDG4 and Extraneal (R), but not in concentrations lower than 30 x MIC and not in Nutrineal (R) PD4 and Physioneal (R) 40. The antimicrobial activity of ampicillin and linezolid is limited in peritoneal dialysis fluids in vitro. Daptomycin is highly effective in peritoneal dialysis fluids and might, thus, serve as an important treatment option in peritoneal dialysis-related peritonitis. Further studies are needed to evaluate the clinical impact of the present findings.
机译:建议腹腔注射抗生素治疗与腹膜透析相关的腹膜炎。但是,关于腹膜透析液和抗菌剂活性之间可能存在干扰的数据很少。因此,本体外研究开始研究不同腹膜透析液对氨苄青霉素,利奈唑胺和达托霉素对粪肠球菌的抗菌活性的影响。用四种不同浓度(1 x MIC,4 x MIC,8 x MIC,30 x MIC)评估每种抗生素在24小时内在四种不同的腹膜透析液中的时间杀灭曲线。阳离子调节的Mueller-Hinton肉汤用作比较溶液。评估的所有四种腹膜透析液均对粪肠球菌的生长具有抑菌作用。与阳离子调节的Mueller-Hinton肉汤比较剂溶液相比,所测试的所有抗生素的抗菌活性均降低。对于氨苄西林和利奈唑胺,无论其浓度如何,在任何腹膜透析液中均未发现活性。达托霉素在所有腹膜透析液中均表现出剂量依赖性活性。在Dianeal(R)PDG4和Extraneal(R)评估的最高浓度下观察到了杀菌活性,但浓度未低于30 x MIC,Nutrineal(R)PD4和Physioneal(R)40则未见。氨苄青霉素的抗菌活性利奈唑胺在体外腹膜透析液中受到限制。达托霉素在腹膜透析液中非常有效,因此可能成为与腹膜透析相关的腹膜炎的重要治疗选择。需要进一步的研究来评估当前发现的临床影响。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号